Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

Market Cap	2.75B +25.5%
Revenue (ttm)	639.10M -9.7%
Net Income	40.35M -44.1%
EPS	0.12 -44.1%
Shares Out	330.95M
PE Ratio	68.25
Forward PE	n/a
Dividend	0.10 (1.20%)
Ex-Dividend Date	May 22, 2025

Volume	3,381,400
Average Volume	5,600,110
Open	8.39
Previous Close	8.33
Day's Range	8.30 - 8.42
52-Week Range	6.12 - 9.68
Beta	0.29
RSI	57.50
Earnings Date	Apr 17, 2026

About SHE:002566

Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers paper packaging products; drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprising acai collagen solid drinks, multivitamin mineral tablets, collagen peptide juice drinks, and fruit lemon powder. It is also involved in pharmaceutic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 1,656
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002566

Financial Performance

In 2024, SHE:002566's revenue was 668.47 million, a decrease of -21.69% compared to the previous year's 853.66 million. Earnings were 52.09 million, a decrease of -45.02%.